Janet Dillione - 09 Dec 2025 Form 4 Insider Report for CorMedix Inc. (CRMD)

Reporting relationship: Director
Issuer ticker: CRMD
Reported as of: 09 Dec 2025
Net transaction value: -$142,100
SEC form: 4
Accepted by SEC: 11 Dec 2025, 08:38:24 UTC
Prior SEC filing: 04 Dec 2025
Next SEC filing: 22 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Janet Dillione

Key filing fact

Janet Dillione filed Form 4 for CorMedix Inc. (CRMD) on 11 Dec 2025.

Key facts

This page summarizes Janet Dillione's Form 4 filing for CorMedix Inc. (CRMD).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 11 Dec 2025, 08:38.

Change

Previous filing in this sequence was filed on 04 Dec 2025.
Current net transaction value: -$142,100.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001489798 Primary reporting owner

Dillione Janet

Relationship: Director
Address: C/O CORMEDIX INC.,, 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS
Signature: /s/ Janet Dillione
Signature date: 11 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRMD transaction

Common Stock

Options Exercise

Transaction value: $181,450
Shares: +19,000
Change %: +39%
Price: $9.55
Shares after: 67,473
Date: 09 Dec 2025
Ownership: Direct

CRMD transaction

Common Stock

Options Exercise

Transaction value: $84,450
Shares: +15,000
Change %: +22%
Price: $5.63
Shares after: 82,473
Date: 09 Dec 2025
Ownership: Direct

CRMD transaction

Common Stock

Sale

Transaction value: $408,000
Shares: -34,000
Change %: -41%
Price: $12.00
Shares after: 48,473
Date: 09 Dec 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRMD transaction Derivative

Stock Option (Right to Buy Common Stock)

Options Exercise

Transaction value: $0
Shares: -19,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 09 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,000
Exercise price: $9.55
Footnotes: F2

CRMD transaction Derivative

Stock Option (Right to Buy Common Stock)

Options Exercise

Transaction value: $0
Shares: -15,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 09 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $5.63
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected

Footnote F2

These options were granted on 02/21/2016. These options are fully vested.

Footnote F3

These options were granted on 02/25/2020. These options are fully vested.